
Journal Menu
► ▼ Journal MenuJournal Browser
► ▼ Journal Browser-
arrow_forward_ios
Forthcoming issue
arrow_forward_ios Current issue - Volumes not published by MDPI
- Vol. 42 (2021)
- Vol. 41 (2021)
- Vol. 40 (2021)
- Vol. 39 (2020)
- Vol. 38 (2020)
- Vol. 37 (2020)
- Vol. 36 (2020)
- Vol. 35 (2020)
- Vol. 34 (2019)
- Vol. 33 (2019)
- Vol. 32 (2019)
- Vol. 31 (2019)
- Vol. 30 (2019)
- Vol. 29 (2018)
- Vol. 28 (2018)
- Vol. 27 (2018)
- Vol. 26 (2018)
- Vol. 25 (2018)
- Vol. 24 (2017)
- Vol. 23 (2017)
- Vol. 22 (2017)
- Vol. 21 (2017)
- Vol. 20 (2016)
- Vol. 19 (2016)
- Vol. 18 (2016)
- Vol. 17 (2015)
- Vol. 16 (2014)
- Vol. 15 (2013)
- Vol. 14 (2012)
- Vol. 13 (2011)
- Vol. 12 (2010)
- Vol. 11 (2009)
- Vol. 10 (2008)
- Vol. 9 (2007)
- Vol. 8 (2006)
- Vol. 7 (2005)
- Vol. 6 (2004)
- Vol. 5 (2003)
- Vol. 4 (2002)
- Vol. 3 (2001)
- Vol. 2 (2000)
- Vol. 1 (1999)
Need Help?
Announcements
12 March 2024
Recruiting Editorial Board Members for the Current Issues in Molecular Biology

Current Issues in Molecular Biology (CIMB, ISSN: 1467-3045) is a peer-reviewed journal publishing original articles and reviews in all areas of molecular biology. To expand our contribution to molecular biology, Current Issues in Molecular Biology is recruiting researchers to join our Editorial Boards of the following Sections:
- “Molecular Medicine”
- “Bioinformatics and Systems Biology”
- “Bioorganic Chemistry and Medicinal Chemistry”
- “Biochemistry, Molecular and Cellular Biology”
- “Molecular Pharmacology”
- “Molecular Plant Sciences”
- “Molecular Microbiology”
The main responsibilities of Editorial Board Members are as follows:
- Making decisions on whether a manuscript should be accepted based on the reports we collect;
- Suggesting special topics or editing a Special Issue on a topic related to your research;
- Promoting CIMB and increasing its visibility at relevant academic conferences;
- Advising on our journal’s development;
- Helping to check Special Issue proposals.
If you are interested in this position, know of potential candidates you would recommend, or wish to request further information, please contact the CIMB Editorial Office. We look forward to hearing from you.
CIMB Editorial Office
12 March 2024
Recruiting Topical Advisory Panel Members for Current Issues in Molecular Biology

The Editorial Office of the Current Issues in Molecular Biology (CIMB, ISSN: 1467-3045) is pleased to announce that applications are open for the Topical Advisory Panel. Should you decide to serve on the Topical Advisory Panel, you would be responsible for some of the following tasks, depending on your availability:
- Providing regular reviews of manuscripts;
- Setting up at least one Special Issue in partnership with a senior researcher within two years of taking on the role and proposing a detailed strategy plan for the Special Issue. The topic of the proposal should be within the scope of CIMB. The scope of the Special Issue should be broad enough to attract a reasonable number of submissions but narrow enough to provide a cohesive collection of articles. The Special Issue should cover a small part of the scope of CIMB;
- Providing a detailed strategy plan for the Special Issue, including assisting in preparing the Special Issue’s title, aim and scope, summary, and keywords, soliciting papers, and promoting the Special Issue;
- Supporting Special Issues related to your expertise when the Guest Editor is unavailable. This includes Special Issue promotion via social media and advising on some scientific cases;
- Promoting our journal at conferences (adding one to two slides into presentations, distributing flyers, recommending the journal to your colleagues, etc.), on social media, and other relevant platforms;
- Working with Editorial Board Members or the Editorial Office to promote high-quality/featured papers (for example, writing summaries or highlights for editor-selected papers).
To qualify as a Topical Advisory Panel Member, applicants must:
- Have expertise and experience in the field related to CIMB;
- Have completed their Ph.D.;
- Have published at least six papers in the last 5 years as a first or corresponding author.
Each year, the members’ performance is evaluated, and outstanding members are promoted to the Editorial Board by the Editor-in-Chief. Please click on the following link to submit your application: https://www.mdpi.com/journal/cimb/topical_advisory_panel_application.
Please do not hesitate to contact the CIMB Editorial Office for further details and clarification.
CIMB Editorial Office
12 March 2024
Current Issues in Molecular Biology | Call for Special Issue Proposals

Current Issues in Molecular Biology (CIMB, ISSN: 1467-3045) is an international, peer-reviewed, and open access journal on all aspects of molecular biology.
The CIMB editorial team is pleased to announce an open call for Special Issue proposals. This Special Issue will offer a group of authors the opportunity to work on an interconnected set of papers on an innovative topic. We welcome high-quality proposals that will be evaluated in an ongoing selection process throughout the year.
In order to ensure that the topic of your proposal is within the scope of CIMB, please read the aim and scope of Current Issues in Molecular Biology at the following website: https://www.mdpi.com/journal/cimb/about.
Proposals for Special Issues should be sent to the Editorial Office or submitted via the following link: https://www.mdpi.com/journalproposal/sendproposalspecialissue/cimb.
The following information should be provided in a proposal:
- A 150–200-word summary that clearly states the significance, novelty, technical advancement, and adherence to the scope of the journal of the proposed topic;
- A list of 5–10 keywords related to the topic;
- A brief resume of the proposed Guest Editors, together with their information (title, name, email, affiliation, personal website, and keywords of their research interests);
- A proposed submission deadline (a Special Issue will usually be open for submissions for 6–8 months);
- A list of at least 20 potential contributors or a list of 8 planned papers.
As a Guest Editor, you would be responsible for:
- Inviting your peers to submit papers to be published in your Special Issue. These papers will be able to take advantage of the high publicity offered by our open access publishing, our rapid and high-quality peer review process, and immediate publication after acceptance;
- Checking the suitability of abstracts/manuscripts submitted to the Special Issue;
- Making pre-check decisions regarding whether to send a new submission to peer review;
- Making final decisions regarding whether to accept a paper based on peer review outcomes.
As a Guest Editor, you would have the following privileges:
- A certificate of recognition as a Guest Editor of CIMB;
- The ability to publish one Feature Paper in your Special Issue;
- The ability to invite authors to submit high-quality papers to be published in your Special Issue with discounts;
- If the Special Issue is successful and features at least 10 manuscripts accepted after full peer review, we can organize it into a printed book and send you a free copy as a gift.
The Editorial Office will set up the Special Issue website, arrange the promotional material, assist with invitations for paper contributions, take care of the administrative tasks associated with peer review, including inviting reviewers, collating reports, contacting authors, and arranging professional production before publication.
Please do not hesitate to contact our Editorial Office if you are interested and would like further details or clarification.
We look forward to receiving your proposals.
CIMB Editorial Office
4 March 2024
MDPI Insights: The CEO's Letter #9 - Romania, Research Integrity, Viruses

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Reka Kovacs (Deputy Office Manager, MDPI), Stefan Tochev (CEO, MDPI), and Sandra Ana Spatariu (Office Manager, MDPI) at the MDPI office in Cluj, Romania.
MDPI’s Impact on Romania
In February, I visited our office in Cluj, Romania. I worked closely with our senior office managers and various teams, including the departments of training, marketing and conferences, as well as our journal relationship specialists, reviewing our service to the local scholarly community. During the visit, I also met with representatives from Babes-Bolyai University and the Technical University of Cluj-Napoca. Our multifunctional Romanian office plays an important role in supporting our collaborations with the local market as well as helping to meet MDPI’s overall business needs.
Feedback and strategy meeting with a group of MDPI’s Journal Relationship Specialists at the MDPI office in Cluj, Romania.
With 22,436 articles, Romania ranks as a top 20 contributing country to MDPI’s total number of papers published as at 28 February 2024. This highlights the importance of our collaboration with Romanian-affiliated authors and the growing opportunity to support their publishing needs. MDPI is one of the few academic publishers with a significant presence in Romania, boasting over 360 colleagues across our offices in Bucharest and Cluj. We are also proud to hire colleagues from local institutions to launch their careers within publishing.
Romania ranks as a top 20 contributing country.
The Numbers: 2019–2023
MDPI has seen a healthy increase in submissions from Romanian authors over the past three years, from 8,439 in 2021 to 11,866 by end of 2023, with most submissions going to journals such as Sustainability, Medicina, Diagnostics, IJMS, Applied Sciences, and JCM. From 2019 to 2023, MDPI published articles from 32,145 authors affiliated with Romanian institutions. Over those years, we have worked with Romanian Guest Editors on nearly 3,000 occasions to support their Special Issue and Topical collections.
With more than 300 Editorial Board Members from Romania, 34 appear on the board of Mathematics, 27 on Materials, 19 on Polymers, 18 on Coatings, and 16 on Molecules, while three serve as Section Editors-in-Chief (SEiC) on our journals Coatings (3.4 IF, 4.6 Citescore), Magnetochemistry (2.7 IF, 3.5 Citescore), and Chemosensors (4.2 IF, 3.9 Citescore).
Institutional Open Access Programs
Our commitment to working with institutions is evident in Romania, where we have established eight Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Bucharest, the University of Medicine and Pharmacy Cluj-Napoca, and most recently the National Institute for Laser, Plasma and Radiation Physics.
Our growth and presence in Romania are a true testament.
We also have IOAP agreements with Babes-Bolyai University and the Technical University of Cluj-Napoca, where I had the opportunity to meet senior stakeholders during my visit. Below are a few photos capturing our meeting with Prof. Radu Silaghi-Dumitrescu (Head of Faculty of Chemistry, Babes-Bolyai University) at the MDPI office in Cluj, Romania, along with a photo from our meeting with Vice Deans Nicoleta Cobarzan, Nicoleta Ilies, and Hoda Gavril, from the faculty of Civil Engineering at the Technical University of Cluj, Romania.


Our growth and presence in Romania are a true testament to the service we provide to the scholarly community and the relationships we foster in that region. We look forward to continuing to support Romanian scholars and institutions by providing a valuable and trusted experience with MDPI, the leader in open access publishing.
Impactful Research
MDPI Joins the STM Integrity Hub
MDPI has long been a supporter and partner of STM, with our involvement ranging from sponsoring and attending events to helping organize event programs. By joining the STM Integrity Hub, we aim to further our commitment to STM initiatives aimed at safeguarding the integrity of science.
“We are pleased to welcome MDPI as the 35th organisation participating in the Hub. This expansion is critical, as every new member enhances our capacity to prevent fraudulent submissions from entering the academic record.”
Joris van Rossum, Director of Research Integrity, STM
MDPI operates in full alignment with STM Integrity Hub's values of shared data and experiences. We strongly believe in collaboration and open exchange for the purposes of creating a holistic approach to support research integrity at MDPI itself and across the entire academic publishing industry. The Integrity Hub is an excellent example of how publishers can come together to jointly address industry-wide challenges related to research integrity, such as manuscripts that breach research integrity standards and paper-mills.
I look forward to our Research Integrity and Publication Ethics Team (RIPE) team immersing themselves in this initiative, exchanging information, best practices, and tools for the benefit of the entire scholarly ecosystem. We believe that ethical publishing standards should be implemented across the board, and we aim to be rigorous in our approach, addressing research integrity issues and improving the impact of published research.
Inside MDPI
MDPI Expands Research Integrity and Publication Ethics Team (RIPE)
In addition to external collaborations and joint initiatives aimed at further strengthening our commitment to research integrity, we are also enhancing our internal efforts. This includes improving our processes and guidelines and expanding our teams and departments to ensure quality assurance throughout our publishing process.
We are pleased to announce the expansion of our Research Integrity and Publication Ethics Team (RIPE) at MDPI. The RIPE team has recently welcomed new colleagues, each bringing unique skills and a personal commitment to prioritize ethical considerations in all our work.
The demand for research integrity and high ethical standards in academic publishing is steadily rising across our industry. Our expanded RIPE team will work to enhance and align our practices with industry best practices, ensuring excellence in research integrity and publication ethics.
Stefan Tochev (CEO, MDPI) introduces Dr. Tim Tait-Jamieson (Research Integrity Lead, MDPI) for his presentation on MDPI’s Retraction and Approval Process to a group of Journal Relationship Specialists at the MDPI office in Cluj, Romania: “The demand for research integrity and publication ethics is steadily rising across our industry.”
Introducing our Research Integrity and Publication Ethics Team
Led by Dr. Tim Tait-Jamieson (Research Integrity Lead), the RIPE team comprises Dr. Ivana Resanovic (Research Integrity Manager), Dr. Lavinia Rogojina (Research Integrity Manager), Ms. Diana Apodaritei (Research Integrity Specialist), Dr. Zoltan Mihaly (Research Integrity Specialist), Mr. Aleksandar Đukić (Research Integrity Specialist), Ms. Ana Stankovic (Research Integrity Specialist), and Ms. Anna Pena (Publication Ethics Assistant).
Please click here to access everything that you need to know about MDPI’s Research and Publication Ethics.
With this span of complementary roles, the RIPE team collaborates directly with journal editorial teams and works closely with various departments, including our Scientific Office Board and our Journal Relationship Specialists. The team’s primary objectives are to help prevent issues regarding research integrity and publication ethics during peer review, uphold MDPI’s ethics policies, adhere to industry standards, and resolve publication ethics and research integrity issues and complaints.
Quality Updates to Special Issues Oversight
At MDPI, we are committed to reviewing policies pertaining to the quality of research. In this blog post, Shaheena Patel (Communications Associate, MDPI), outlines two recent updates to MDPI journal processes. These updates pertain to Special Issue (SI) quality guidelines, in line with criteria provided by COPE and DOAJ. Alongside the SI updates, details regarding the new minor corrections policy introduced in 2024 are provided in the blog.
The two updates we implemented include greater oversight and the verification of Guest Editor credentials. These guidelines require that Editors-in-Chief (EiCs) and Editorial Board Members (EBMs) take responsibility for overseeing SIs.
PS. Thank you, James Butcher, for featuring this up in your 67th issue of the Journalogy newsletter.
Read more:
Coming Together for Science
Viruses 2024 – A World of Viruses
I am pleased to share the success of our MDPI conference Viruses 2024 – A World of Viruses, held 14-16 February, in Barcelona. With 240 registrations, this event brought together top scientists, researchers, and industry experts from 40 countries to share their findings on the latest developments in viral pathogenesis and immune responses.
Attendees gathered for the 5th edition of the Viruses’ conference, where we hosted influential keynote speeches from Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes, along with 14 invited speakers, 47 selected speakers, and nine flash poster presenters, to discuss the most significant issues in virology today.
Recap on the #Viruses2024 Conference
Take a look at the key moments from MDPI’s Viruses event and please join us in commemorating a gathering for global knowledge and cooperation. A heartfelt thank-you to all attendees; their passion and engagement played a crucial role in making this event an engaging success!
Below are calls to action from the keynote speakers encouraging collaboration and communication:
“There’s never been a better time than now to really take the power that we have both in terms of basic research and also in biotech and pharma to develop antiviral agents.” - Dr. Charles M. Rice, The Rockefeller University, New York, USA
“The collaboration between labs is absolutely essential. Improving initial detection and improving communication is a must for all of us working in science.” - Prof. Dr. Luis Enjuanes, National Center of Biotechnology (CNB-CSIC), Madrid, Spain
Our thanks go to our sponsors and partnering societies, our Viruses journal and editorial team, our Barcelona colleagues, and the social media, conference and other MDPI teams for making this event a memorable occasion. View the event gallery here.
Upcoming In-Person Event
24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities
Location: Barcelona, Spain
Esteemed speakers at MMCS 2024 include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.
Find more upcoming MDPI events here.
Organize Your Event with MDPI’s Sciforum
Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.
Closing Thoughts
Researcher to Reader (R2R) Conference
From 20–21 February 2024, I had the pleasure of attending the Researcher to Reader (R2R) conference in London, which MDPI has proudly sponsored over the years. The conference programme offered a variety of session formats, including workshops, panel discussions, debates, interviews, presentations, and lightning talks, with opportunities to discuss relevant topics.
We take pride in supporting the scientific community, bringing researchers across the world together to network, exchange ideas and share the latest in science and publishing. In 2023, MDPI invested close to 2 million CHF in sponsoring over 2,000 scientific and publishing-related conferences worldwide.
R2R Peer Review Innovations Workshop
I found the R2R conference to be engaging, with the workshops being particularly enjoyable. My colleague Giulia Stefenelli (Chair of Scientific Office Board) and I participated in the “Peer Review Innovations” workshop, which spanned four sessions over the two days. These sessions explored the future of peer review and how we can improve the peer review process for everyone involved. Notably, the large majority of attendees expressed their opinion that peer review, as currently practiced, requires significant improvement. Together, we collaborated on potential immediate and long-term improvements and innovative processes, aiming to create an ecosystem beneficial to all stakeholders by strengthening submission systems with the aim of reducing threats and making authors more responsible for their work. We also discussed the opportunity for academic institutions to better scrutinize the quality of the work produced and submitted to journals.
Our group comprised publishers, software providers, librarians, and more, bringing diverse perspectives to the discussions. These interactions were relevant to MDPI’s ongoing conversations, providing insights to our efforts. The session also made me appreciate that MDPI is doing well, as the group discussions included the subject of various quality checks that we have already embedded in our processes, ensuring that we keep abreast of industry standards.
The need for an optimized system to incentivize the activities of editors and reviewers was also a focus of discussion, as well as the support that reviewers need from publishers via the provision of strong reports through fixed forms, questionnaires and training.
At MDPI, we are currently auditing our reviewer program to improve reviewer recognition, guidelines, and methods for identifying suitable reviewers, while maintaining our commitment to quality and timeliness.
Congratulations to Mark Carden, Conference Director, and the R2R team for organizing a productive and successful event. PS: The break times were greatly appreciated as well!
Chief Executive Officer
MDPI AG
21 February 2024
Meet Us at ACS Spring 2024—Many Flavors of Chemistry, 17–21 March 2024, New Orleans, LA, USA

Conference: ACS Spring 2024
Organization: American Chemical Society
Date: 17–21 March 2024
Place: Halls D & E, New Orleans Ernest N. Morial Convention Center, New Orleans, LA, USA
Booth: #2530
MDPI journals will be attending ACS Spring 2024—Many Flavors of Chemistry as an exhibitor. This meeting will be held in New Orleans, LA, USA, from 17 to 21 March 2024.
The American Chemical Society (ACS) is one of the world’s largest scientific organizations with more than 151,000 members in 140 countries. ACS meetings and expos are held biannually. This expo is an opportunity for thousands of chemistry professionals to meet, share ideas, and advance scientific and technical knowledge. The topic in Spring 2024 is “Many Flavors of Chemistry”.
The following MDPI journals will be represented:
- Materials;
- Molecules;
- DDC (Drugs and Drug Candidates);
- Batteries;
- Chemistry;
- Colorants;
- Cosmetics;
- Fibers;
- Inorganics;
- Organics;
- Polymers;
- Separations;
- Symmetry;
- Analytica;
- AppliedChem;
- CIMB (Current Issues in Molecular Biology);
- Coatings;
- Crystals;
- Energies;
- JFB (Journal of Functional Biomaterials);
- Liquids;
- Magnetochemistry;
- Membranes;
- Reactions;
- Sustainable Chemistry.
If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following website: https://www.acs.org/meetings/acs-meetings/spring.html.
6 February 2024
Meet Us at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024), 27–30 April 2024, Barcelona, Spain

MDPI will attend the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) as an exhibitor. This conference will be held in Barcelona, Spain, from 27 to 30 April 2024.
The following MDPI journals will be represented:
- JCM;
- JPM;
- Pathogens;
- Antibiotics;
- Diagnostics;
- Biomolecules;
- Life;
- Venereology;
- IJMS;
- Microorganisms;
- TropicalMed;
- Medical Sciences;
- CIMB.
If you are attending this conference, please feel free to start a conversation with us at our booth. Our delegates look forward to meeting you in person and answering any questions that you may have.
For more information about the conference, please visit https://www.eccmid.org/.
31 January 2024
MDPI Insights: The CEO's Letter #8 - Altmetric and Flat Fee Agreement

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
MDPI and Digital Science Meeting
At MDPI, we are committed to providing our authors with the essential tools to publish, promote, and track their research. In line with this commitment, we have established a longstanding collaboration with Digital Science, a company specializing in research data and analytical insights for the research community. Our collaboration integrates their Altmetric tool, offering us and our authors the ability to track a variety of sources that monitor and report attention surrounding publications.
As part of our collaboration, we recently hosted Cathy Holland, Director of Global Publisher Business Development, and Helen Cooke, Managing Director of Publisher Sales, from Digital Science, at our MDPI headquarters in Basel, Switzerland.
Left to right: Facundo Santomé (Senior Marketing Manager, MDPI), Constanze Shelhorn (Indexing Manager, MDPI), Cathy Holland (Director of Global Publisher Business Development, Digital Science), Helen Cooke (Managing Director of Publisher Sales, Digital Science), and Stefan Tochev (CEO, MDPI) in front of MDPI headquarters in Basel, Switzerland.
During our meeting, we discussed MDPI’s publishing philosophy and explored further avenues for collaboration. We look forward to continuing our partnership with Digital Science, aiming to improve our services yet further and meet the needs of our authors more closely than ever.
What is Altmetric?
You will notice that MDPI articles feature an Altmetric score, a colourful doughnut capturing the score in the upper right corner of the article page. This score represents ‘alternative metrics,’ as distinct from traditional metrics such as Impact Factor, CiteScore, and Scimago Journal Rank.
Altmetrics complement traditional citation-based metrics by capturing online discussions related to a specific research topic. By analyzing both sets of data, we can obtain a comprehensive understanding of the attention a particular research output receives and the sources in which it is mentioned.
“Almetric provides visual insights into where research is being discussed”
Sources Tracked by Altmetric
Altmetric badge showing the Altmetric score and colour-coded mention sources.
Altmetric monitors various sources, categorizing them into segments such as policy documents, peer reviews, Wikipedia, news and blogs, and social media, among other sources. Each category is identifiable by a specific colour.
The Altmetric badge provides visual insights into where the research is being discussed. A more colourful badge indicates broader mentions across multiple platforms. Such tracking enables us to gauge the extent of an article’s online dissemination, noting that increased visibility may correlate with higher citation rates.
Read more:
Impactful Research
Ten High-Altmetric Articles Published by MDPI
As at 30 January 2024, Altmetric has tracked 670,500 MDPI research outputs from MDPI, resulting in over 4.3 million mentions. This includes over 71,894 mentions in policy and patents and 294,714 mentions in news and blogs, with some achieving an Altmetric score as high as 28,754.
So, what is a good Altmetric score? There are various ways to put this score into context. You can find out more about the score in context and how to evaluate your work by this means.
Here are ten MDPI papers ranking in the top 5% of all research outputs scored by Altmetric.
|
“Accuracy in Wrist-Worn, Sensor-Based Measurements of Heart Rate and Energy Expenditure in a Diverse Cohort” J. Pers. Med. 2017, 7(2), 3; https://doi.org/10.3390/jpm7020003 Altmetric page: https://mdpi.altmetric.com/details/20477344 Altmetric shows that this article appeared in 253 news stories from 209 outlets including Forbes, BBC, and Fox News. |
|
“Daylight Saving Time and Acute Myocardial Infarction: A Meta-Analysis” J. Clin. Med. 2019, 8(3), 404; https://doi.org/10.3390/jcm8030404 Altmetric page: https://mdpi.altmetric.com/details/57654628 Altmetric shows that this article appeared in 295 news stories from 207 outlets including Forbes, The Atlantic, and New York Times. |
|
“The Preliminary Analysis of Cave Lion Cubs Panthera spelaea (Goldfuss, 1810) from the Permafrost of Siberia” Quaternary 2021, 4(3), 24; https://doi.org/10.3390/quat4030024 Altmetric page: https://mdpi.altmetric.com/details/111086701 Altmetric shows that this article appeared in 182 news stories from 134 outlets including CBC News, CNN, and National Geographic. |
|
“Not the Cat’s Meow? The Impact of Posing with Cats on Female Perceptions of Male Dateability” Animals 2020, 10(6), 1007; https://doi.org/10.3390/ani10061007 Altmetric page: https://mdpi.altmetric.com/details/83796184 Altmetric shows that this article appeared in 124 news stories from 98 outlets including VICE, CNN and The Guardian. |
|
“Behaviour and Welfare Impacts of Releasing Elephants from Overnight Tethers: A Zimbabwean Case Study” Animals 2022, 12(15), 1933; https://doi.org/10.3390/ani12151933 Altmetric page: https://mdpi.altmetric.com/details/133463915 Altmetric shows that this article appeared in 192 news stories from 186 outlets. |
How do I use altmetrics?
Altmetric Explorer provides a detailed step-by-step guide and instruction video for first-time users of the tool. The guide includes useful diagrams that make it easy to get started.
Sharing Research Online
For research to be tracked across different sources, Altmetric needs a research output with a persistent identifier: a DOI, ISBN, PubMed ID, handle ID, etc. When sharing research, it is important to include a link to the original research output.
|
“An Update on Eukaryotic Viruses Revived from Ancient Permafrost” Viruses 2023, 15(2), 564; https://doi.org/10.3390/v15020564 Altmetric page: https://mdpi.altmetric.com/details/142929875 Altmetric shows that this article appeared in 250 news stories from 180 outlets including CTV, Fox News, and CNN. |
|
“The Global Problem of Insufficient Sleep and Its Serious Public Health Implications” Healthcare 2019, 7(1), 1; https://doi.org/10.3390/healthcare7010001 Altmetric page: https://mdpi.altmetric.com/details/53406248 Altmetric shows that this article appeared in 252 news stories from 168 outlets including BBC, Harvard Business Review, and Forbes. |
|
“A Detailed Review Study on Potential Effects of Microplastics and Additives of Concern on Human Health” Int. J. Environ. Res. Public Health 2020, 17(4), 1212; https://doi.org/10.3390/ijerph17041212 Altmetric page: https://mdpi.altmetric.com/details/86529137 Altmetric shows that this article appeared in 197 news stories from 150 outlets including BBC, The Tribune, and World Economic Forum. |
|
“An Empirical Study of Chronic Diseases in the United States: A Visual Analytics Approach to Public Health” Int. J. Environ. Res. Public Health 2018, 15(3), 431; https://doi.org/10.3390/ijerph15030431 Altmetric page: https://mdpi.altmetric.com/details/34714141 Altmetric shows that this article appeared in 232 news stories from 149 outlets including Forbes, New York Times, and Harvard Business Review. |
|
“Garden Scraps: Agonistic Interactions between Hedgehogs and Sympatric Mammals in Urban Gardens” Animals 2023, 13(4), 590; https://doi.org/10.3390/ani13040590 Altmetric page: https://mdpi.altmetric.com/details/142934305 Altmetric shows that this article appeared in 172 news stories from 168 outlets including BBC. |
Inside MDPI
MDPI Annual Meeting Celebrations in China
On Thursday 25 January, over 1,300 MDPI colleagues from our two offices in Beijing gathered to kick off MDPI’s traditional ‘Annual Meetings.’ These celebrations take place in MDPI’s offices across China, including Dalian, Tianjin, Wuhan, and Nanjing.
The evenings include performances, informative talks and presentations, awards, and entertainment, providing an ideal platform to recognize our colleagues, celebrate their achievements, and set our sights on the future.
“It is essential that we stay connected and share best practices”
I sent a video congratulating everyone on their work and sharing our vision of building MDPI into the most trusted OA publisher, highlighting the roles each of us has to play in achieving that goal.
Unfortunately I could not join in person, but you may recall my recent trip, when I visited our offices in Beijing and Wuhan, which I look forward to visiting again this year.
Although our headquarters are in Basel, Switzerland, and we are expanding throughout Europe and North America, the majority of MDPI’s workforce is in China and throughout the Asia-Pacific region, including offices in Singapore, Thailand, Japan, and newly opened office in South Korea. It is essential that as a global organization, we stay connected and share best practices in order to grow collectively and continue providing the exceptional service to our authors.
The Annual Meeting is a moment to reflect and enjoy the year’s hard work and dedication.
I extend our best wishes to all for the Chinese New Year (Xīnnián kuàilè)!
Coming Together for Science
MDPI and TU Delft Adopt Flat Fee Model in Extended Partnership
We are excited to announce a renewed three-year partnership with Delft University of Technology (TU Delft) in the Netherlands. This collaboration introduces a fixed lump-sum fee, covering publishing costs from 2024 to 2026.
“This initiative reflects our dedication to transparent and inclusive publishing”
TU Delft-affiliated authors will enjoy cost-free publishing in any MDPI journal during this period, aligning with our commitment to removing barriers for open access publishing. The agreement supports Plan S compliance and facilitates a seamless publishing process for TU Delft corresponding authors. This initiative reflects our dedication to transparent and inclusive publishing, providing stability and predictability both for authors and for institutions.
For further details on our Institutional Open Access Program (IOAP), please contact us.
Benefits to MDPI’s IOAP
At MDPI we have a long tradition of partnerships, including our Institutional Open Access Program (IOAP). IOAP supports institutions through simplification, access, transparency, APC discounts, and institutional repository deposits. The program simplifies administrative processes, offers central payment, and allows easy opting in and out. Participants gain free access to Susy, MDPI’s online submission system, with extensive article metadata and exportable data. APC discounts and Book Processing Charge discounts are available for affiliated authors. Automated deposits to institutional repositories and streamlined matching of papers to IOAP participants enhance the overall experience.
For further information, see our IOAP FAQ.
Closing Thoughts
Reflections on the 2024 APE Conference
MDPI was proud to co-sponsor the Academic Publishing in Europe (APE) 2024 Conference that took place in Berlin, Germany, from 9–10 January 2024.
The conference theme, ‘Keep the Conversation Going!’, explored the evolving landscape of scholarly communication. APE is one of the key conferences I make a point to attend each year. January offers a valuable opportunity to engage with new contacts, reconnect with familiar faces, and participate in impactful discussions and presentations among professionals, scholars, and practitioners in the field.
“It's fascinating to see how other publishers are leveraging AI”
Highlights
Some of the standout panels for me include: the role of the UN Sustainable Development Goals (SDGs) within the publishing industry. It was encouraging to hear the current status quo, though I was eager also to learn about the exciting projects planned for 2024 and beyond. These will allow us to track progress in subsequent years. At MDPI, we remain committed to promoting Open–Access (OA) content on SDGs through scientific articles and books. Furthermore, we extend our commitment to sustainability by financially supporting researchers through initiatives such as the World Sustainability Award and the Emerging Sustainability Leader Award, as well as waiving the APC for feature papers on each SDG.
In recent years, discussions on AI have become increasingly prominent at such conferences. It’s fascinating to see how other publishers are leveraging AI to meet the evolving needs of their audiences while at the same time using it to safeguard the scientific process. Other engaging panels that I enjoyed included updates on transformation beyond transformative agreements, the principles of lean change, incentive structures related to research integrity, and the panel on reviewer incentives.
“We can share best practices and lessons learned”
Incorporating MDPI’s Insights into Conferences
I must confess that I sometimes feel overlooked when MDPI is not invited to participate in crucial industry discussions. As the leading open access publisher and the third-largest publisher overall, we possess extensive experience in many of these areas and can offer valuable contributions to these discussions. We can share best practices, lessons learned, and our thinking about future trajectories. For instance, in panels discussing reviewer incentives, at MDPI we offer a discount voucher to reviewers for future submissions, reflecting our commitment to fostering a robust peer review process. In 2022 alone, MDPI collected over 1.4 million peer review reports, informing the decision-making processes of our editors. Given our expertise in these areas, it would be natural to include MDPI in such discussions. I therefore extend an invitation to future conference organizers to consider MDPI for speaking engagements and collaborative opportunities.
Chief Executive Officer
MDPI AG
24 January 2024
Acknowledgment of the Reviewers of Current Issues in Molecular Biology in 2023
In recognizing the exceptional efforts of our reviewers in 2023, we express our sincere gratitude for upholding the high standards of Current Issues in Molecular Biology. Their commitment ensured the rigorous peer review that is integral to quality academic publishing.
In 2023, Current Issues in Molecular Biology received 2188 review reports, from 1972 reviewers. This past year, we worked with reviewers from 76 countries and regions, reflecting the diversity in our collaboration with research communities. Their dedication shapes scholarly discourse and advances global research. The editorial team expresses gratitude for the vital role played by each reviewer in the Current Issues in Molecular Biology family throughout 2023, and we look forward to their continued support in 2024.
The following are the reviewers who have consented to show their names:
A. N. M. Mamun-Or-Rashid | Liang Hu |
Aadil Javed | Liang Zhong |
Abdellatif Bouazzaoui | Libo Zhang |
Abdul Basit | Linda Myers |
Abhishek Mishra | Linda Peters |
Aditya Sharma | Liubov Gorbacheva |
Adriana Fodor | Liudmila Lysenko |
Adriana Grigoraș | Liviu Macovei |
Adriana Urcan | Liyun Liu |
Ahmed Abdellatif | Lokesh Kumar |
Ahmet Cingoz | Luca Giacomelli |
Ahsanullah Unar | Luciana Bordin |
Aijaz Bhat | Lucio Mango |
Aimin Jiang | Luís Félix |
Akiko Sakai-Sakasai | Luis Ibarra |
Alberta Mandich | Luis Piñeiro |
Aleksandar Simović | Luis Soto-Rojas |
Aleksandr Kichigin | Lukasz Dobrek |
Aleksandra Asaturova | Łukasz Szeleszczuk |
Aleksandra Józefczyk | Lyudmila Bel'Skaya |
Aleksandra Klisic | Magda Abdellattif |
Aleksandra Trzewik | Magdalena Machowska |
Alessandra Ferramosca | Magdalena Mroczek |
Alexa Klettner | Magdalena Piekutowska |
Alexandr Ceasovschih | Maged Elghannam |
Alicia Ayerdi Gotor | Maha Nasr |
Allen Titus | Mahendran Chinnappan |
Alsu Lubyanova | Maher Abdalla |
Althaf Shaik | Mahmoud Balbaa |
Amanda Iglesias | Mahmoud Kandeel |
Ameth Hawkins-Villarreal | Maikel Castellano-Pozo |
Amir Ashoorzadeh | Majid Ghareghani |
Amira Ibrahim | Malgorzata Zieba |
Amiya Patra | Mangesh Yuwaraj Dudhe |
Ammad Ahmad Farooqi | Manish Kumar |
Amro Amara | Márcio Formiga |
Ana Duarte | Marco Cavaco |
Ana Moreno Alvarez | Marcus Mareel |
Ana Silva | Marek Gancarz |
Ana Sofia Vallés | Marek K. Bernard |
Anastasios Alatzas | Marek Murias |
Anbazhagan Sathiyaseelan | Marek Wesolowski |
Andrea Mastinu | Margarete Odenthal |
Andreas Brodehl | Margherita Eufemi |
Andreas Savelsbergh | Margherita Neri |
Andrei Ivanov | Maria Addolorata Mariggiò |
Andreia Garces | Maria Elena Padín-Iruegas |
Andrey Plotnikov | Maria Rita Bianco |
Aneta Ostróżka-Cieślik | María Teresa Llinas Más |
Ángel Juan García Yagüe | Maria-Jimena Mucino-Bermejo |
Angel M. Cuesta | Mariana Floria |
Angela Quispe-Salcedo | Mariapaola Marino |
Angeliki Angelidi | Mariia Ivanova |
Anita Kloss-Brandstätter | Marina Kopaeva |
Anna Bilska-Wilkosz | Marina Piscopo |
Anna Ogrodowczyk | Marino Paroli |
Anna Piotrowska | Mariusz Hartman |
Anna Szakiel | Mariusz Niemczyk |
Anna Wiktorowska-Owczarek | Martha Alejandra Morales-Sánchez |
Annalisa Chianese | Marzena Mogielnicka-Brzozowska |
Antimo Di Maro | Maša Ždralević |
Anton S. Tsybko | Masashi Mizuguchi |
Anton Terasmaa | Massimiliano Ammirabile |
Antonella Ragnini-Wilson | Massimiliano di Pietro |
Antonella Virgilio | Matt Spick |
Antonio Guaita | Maurizio Badiani |
Anupam Mukherjee | Mauro Lombardo |
Anushka Gupta | Mayank Choubey |
Ao Shi | Mehraju Lone |
Apostolos Papachristos | Mehran Ghaemi |
Ari Meerson | Mehran Ghasemzadeh |
Arianna De Mori | Mengdi Bao |
Arijit Kundu | Mercedes Bermúdez |
Artem Badasyan | Mercedes Fernandez |
Artur Słomka | Michael Davis |
Arun Kharat | Michael Petronek |
Arun Kumar Hanumana Gouda Patil | Michael Schreiber |
Atefeh Najafi | Michaela Cellina |
Atefeh Sabouri | Michele Finotti |
Athanasios Papakyriakou | Mihaela Begea |
Athar Ansari | Mihaela Ileana Ionescu |
Avinash Mishra | Mikaeel Young |
B.H. Jaswanth Gowda | Mikhail Akimov |
Babak Pakbin | Mikhail Dubinin |
Bac Viet Le | Mikhail Moskalik |
Barani Kumar Rajendran | Mikko Laukkanen |
Beata Mrozikiewicz-Rakowska | Milana Trifunović-Momčilov |
Beatrice Ferrari | Milica Pešić |
Belaghihalli Gnanesh | Milos Lazarevic |
Belgin Sever | Minghao Luo |
Berwin Singh Swami Vetha | Ming-Wei Lin |
Bhupinder Kumar | Mircea Ioan Popa |
Bi-He Cai | Miriam Echevarría |
Bing Liu | Mirolyuba Ilieva |
Biswajit Padhy | Mirosław Wyszkowski |
Bohao Fang | Mohamed Ali |
Bojin Bojinov | Mohamed Mohamed Kamara |
Boleslaw T. Karwowski | Mohammad Uddin |
Boris Krasnikov | Mohsin Jafri |
Boris Stambuk | Monika Ruszala |
Boryana Nikolova-Mladenova | Mubarak Mustapha |
Calin Corciova | Muhammad Ahsan Asghar |
Carlos Prada Quirogaa | Muhammad Ayaz |
Carmen Ramírez | Muhammad Ikram |
Carmine Izzo | Muhammad Mahmood |
Catana Cristina | Muhammed Batir |
Catherine Yzydorczyk | Mukesh Choudhary |
Cecilia Taverna | Mukund Tantak |
Céline Koster | Muralidharan Arumugam Ramachandran |
Cesare Danesino | Nagendra Chauhan |
Chandra Mukhopadhyay | Nancy Saad |
Chao Ma | Narongchai Autsavapromporn |
Chao Wang | Natalia Yanguas Casás |
Chennaiah Ande | Neeraj Chauhan |
Chiara Calabrese | Neeraj Thakur |
Chiara Reale | Nemat Ali |
Chih-Li Lin | Nesrein Hashem |
Chih-Wei Zeng | Nethaji Muniraj |
Chiranjeev Sharma | Netty Salindeho |
Christian Gernhardt | Nidhi Puranik |
Christian Laboisse | Nir Erdinest |
Christian Wiraja | Nirmalya Dasgupta |
Christina Oetzmann Von Sochaczewski | Nitesh Shashikanth |
Christine Bone | Nithyananthan Subramaniyam |
Christos Papaneophytou | Noha Hammad |
Claire Stocker | Noopur Bhatnagar |
Claudia Villicaña | Noor Saidi |
Claudiu N. Lungu | Norrie Pearce |
Constantin Munteanu | Nurpudji Astuti Taslim |
Cosimo Galletti | Oksana Tuchina |
Cristian Canales-Aguirre | Oleg Shuvalov |
Cristina Gluhovschi | Olga Tsivileva |
Cristina Neves | Otávio Augusto Chaves |
Cyril Fersing | Oyuna Kozhevnikova |
Dainis Rungis | Pan Zhang |
Dana Lucia Stanculeanu | Panagiotis Mallis |
Daniel Potaczek | Pankaj Gaur |
Daniela Giordano | Pao-Chu Chen |
Daniela Stoin | Paola Sinibaldi |
Daniele Vergara | Paolo Mariani |
Dario Giorgio | Paolo Paoli |
Dario Siniscalco | Paranita Ferronika |
Dariusz Piwczyński | Pascal Gottmann |
David Chambers | Paschalis Theotokis |
De-Li Shi | Pasquale Stano |
Demetrios Arvanitis | Patrick Martin |
Diana Kata | Paul Viscuse |
Diana Torge | Paula Fernández-Palanca |
Dmitry Gruzdev | Pauline Schneider |
Dmitry Shulga | Pedro Ferreira-Santos |
Domagoj Šubarić | Pedro Piedras |
Domenico Ferro | Perumal Ponraj |
Dominik Dłuski | Petar Brlek |
Dominika Zając | Peter Piko |
Dong-Dong Wu | Petras Prakas |
Dong-Gwan Kim | Petya Christova |
Donghwa Kim | Pezhman Mahmoodi |
Dorota Olszewska-Słonina | Pia Giovannelli |
Dragos Mihai | Piotr Dobrowolski |
Dragos Serban | Piotr Szymczyk |
Dusan Dimic | Prabhanjan Giram |
Eddie Mondejar | Prasath Manogaran |
Edson Roberto da Silva | Prashant Kaushik |
Edward Muntean | Prashanth Ravishankar |
Ekaterina F. Kolesanova | Purushoth Ethiraj |
Elena Grossini | Qian Zhang |
Elena Matei | Qilei Chen |
Elena Panizza | Qingming Fang |
Elena Tchetina | Qiuwang Zhang |
Elena Zavyalova | Qiwen Deng |
Eleonore Fröhlich | Quan Pan |
Elio Romano | Rahul Jawarkar |
Elsayed Mansour | Rahul Mandal |
Elsayed Mehana | Rajmohan Dharmaraj |
Eman Fayad | Rama Rao Tata |
Eman Toraih | Rami Najjar |
Emilia Severin | Rashmi Panigrahi |
Emma Adriana Ozon | Ravi Sharma |
Eric Huet | Ravindran Caspa Gokulan |
Eva Matzhold | Raymond L. Konger |
Evangelia Antoniou | Rebekka Heitmar |
Evgen Multia | Reda Bellaouchi |
Ewa Tomaszewska | Rex Nelson |
Fabio Del Duca | Rey David Vargas Sánchez |
Fanfan Hao | Reza Shirazi |
Fatih Hatipoglu | Reza Zolfaghari Emameh |
Fatima Khan | Ricardo Gil-Ortiz |
Fatma El-Demerdash | Richard Kast |
Fatma Eldemery | Rigers Bakiu |
Fernando Cardona | Rita Araújo |
Fernando Ferreira | Robert Eibl |
Filippos Triposkiadis | Robert Kleszcz |
Flavia Graca | Robert Lafrenie |
Flora N. Balieva | Robert Sharp |
Flora Tsvetanova | Roberta Gasparro |
Florica Sandru | Roberto Piergentili |
Francesca Cardano | Rodolfo Reda |
Francesca Sanguedolce | Rogerio Buchaim |
Francesco Sessa | Roman Maslennikov |
Franco Mutinelli | Rosa Suades |
Fulvio Ciriaco | Rosario Sarabia |
Gábor Kökény | Roshan Katekar |
Gabriel Marc | Roua Popescu |
Gabriela Goujgoulova | Roxana Liana Lucaciu |
Gabriela Iancu | Roxana-Maria Amarandi |
Gaetano Marverti | Rúben Fernandes |
Galina Nikolova | Rumyana Simeonova |
George Gamov | Ryan Henry |
George Imataka | Sabina Galiniak |
Georgiana-Emmanuela Gilca-Blanariu | Sagarika Mishra |
Georgios Pampalakis | Sandra Sobocanec |
Gerardo Casanola-Martin | Santi Mandal |
Giampiero Cai | Sara Caceres |
Giannotta Girolamo | Sarmad Al-Marsoummi |
Gil Fraqueza | Satyesh K. Sinha |
Giovanna Rigillo | Saumya Anang |
Giovanni Levi | Savvas Lampridis |
Giovanni Ribaudo | Sayali Onkar |
Giuseppe Lanzarone | Sebastian Glowinski |
Giuseppe Montalbano | Sebastiano Cicco |
Giuseppe Puglia | Senija Eminović |
Giuseppina Basini | Serena Vittorio |
Gopinath Prakasam | Sergey Tkachev |
Gordana Wozniak Knopp | Sergio Ochatt |
Gregory Cole | Seung Kyu Lee |
Grigorios Dimas | Shalini Dogra |
Grzegorz Bartosz | Shankar Jaikishan Evani |
Guanying Xu | Shehwaz Anwar |
Guglielmo Mantica | Shigeki Sugawara |
Guillaume St-Jean | Shimaa Amer |
Gundula Schulze-Tanzil | Shining Loo |
Guo-Ping Zhan | Shivendra Kumar |
Györgyi Műzes | Shuo Deng |
Ha Chu | Shweta Tripathi |
Hadel Abo El Enin | Sigit Prastowo |
Haiyan Yang | Silvano Dragonieri |
Hala Mohamed El Hefnawy | Silvia Angelova |
Hao Wu | Simona Dedoni |
Harikanth Venkannagari | Simona Errico |
Haruhiko Sugimura | Simone Cilio |
Hassan Ishqi | Sinian Char |
Héctor Mora-Montes | Sirajudheen Anwar |
Hee-Geun Jo | Sishir Kamalapuram |
Hemangi Bhonsle | Siwei Zhang |
Hesham Haffez | Sneha Pillai |
Hexiao Wang | Sohail |
Hiroyuki Kataoka | Sok Kuan Wong |
Hiroyuki Noda | Sotirios N. Kiokias |
Hossein Sabahi | Sotirios Zarogiannis |
Houshang Nemati | Sourav Chattopadhyay |
Howard Boudreau | Stergios Boussios |
Hsiu-Mei Chiang | Steven Esworthy |
Ibrahim Sayed | Sudhir Shende |
Ignacija Vlašić | Suman Mukhopadhyay |
Ignacio Badiola | Sumeet Nayak |
Igor Ovchinnikov | Susana Belén Bravo López |
Ilahy Riadh | Susana Lechuga |
Iliyan Ivanov | Susheel Gulati |
Ilya Seregin | Svetoslav Dimov |
Ilze Strumfa | Swapan Ghosh |
Iman Sherif | Syed Azmal Ali |
Ines Aguinaga-Ontoso | Syed Mohd Faisal |
In-Sul Hwang | Tadeusz Kowalski |
Ionel Alexandru Checherita | Takatsune Shimizu |
Irene Righetto | Takemichi Fukasawa |
Irina N. Anisimova | Takuji Ohyama |
Irina Shubina | Takumi Abe |
Ismael Hernández-Ávalos | Takumi Ishizuka |
Iulia-Ioana Stanescu-Spinu | Tasneem Arsiwala |
Ivana Šagud | Tatjana Radosavljević |
Izabel Cristina Rodrigues da Silva | Tatsuo Kanda |
Izabela Łasińska | Telbisz Ágnes |
J Leopoldo Aguilar-Faisal | Teresa Tellez Santana |
Jakub Rok | Teru Kamogashira |
James Arnone | Thayne Kowalski |
James Chow | Theodoros Karalis |
James Hunter | Therese Riedemann |
Jan Bocianowski | Ting-Wen Lo |
Jana Sopkova-de Oliveira Santos | Tomasz Cebulak |
Janitschke Daniel | Tomasz Płoszaj |
Jaroslaw Smieja | Tomasz Szablewski |
Javier Saenz-Medina | Tracey Madgett |
Jayeshbhai Chaudhari | Tung Nguyen-Thanh |
Jean Boutin | Vadim Lebedev |
Jean-Marie Exbrayat | Vahideh Rabani |
Jeong Yeon Kim | Vairavel Parimelazhagan |
Jesús Adrián López | Valeria Rachela Villella |
Jia Li | Valeria Segatori |
Jiangnan Peng | Valeria Sogos |
Jianhai Chen | Vasil Georgiev |
Jieqiang Zhong | Veronica Filetti |
Jing Ma | Victor Martin |
Jinlong Liu | Victor Seledtsov |
Joachim Greilberger | Victoria Sanchez-Martin |
Joanna Zarzyńska | Vinay Shivanna |
João Henrique G. Lago | Violeta Oro |
Joao Pessoa | Vishnuprabu Durairaj Pandian |
João Simões | Vladimir Chobot |
John Triantafillidis | Vladimir Tesar |
Johura Ansary | Vladimira Boyadzhieva |
Jon Schoorlemmer | Vyacheslav Arlyapov |
Jonathan Rayner | Wai San Cheang |
José Luis Subiza | Walther Bild |
Jose Mulet | Wei Guo |
Jozsef Dudas | Wei Li |
Juan Guzman-Flores | Wei Zhou |
Julian J. Freen-van Heeren | Weihua Huang |
Junquan Liu | Wenyi Wang |
Kamalakannan Radhakrishnan | Wesley Raup-Konsavage |
Karan Arora | Wiesław Bielas |
Karolina Gołąbek | Willibald Wonisch |
Karthikeyan Subbarayan | Wojciech Szlasa |
Karthikeyan Thiyagarajan | Wojciech Trybus |
Karunakar Reddy Pothula | Won Kyong Cho |
Katherine Theken | Work Złotkowska |
Ken Rosenthal | Xiang-Fei Li |
Kentaro Okamoto | Xiaokang Wu |
Khaled F. Salem | Xin Bi |
Khaleel Jawasreh | Xinglin Yang |
Ki-Cheong Park | Xingyi Yang |
Kirk Stephenson | Xinhong Chen |
Kit-Leong Cheong | Xinyuan Lei |
Klaus Jung | Xolani H. Makhoba |
Kok Lun Pang | Yanan Liu |
Konstantin Belosludtsev | Yara Michelacci |
Konstantin Kozlov | Yasemin Yücel |
Konstantinos Arvanitakis | Yaser Peymanfar |
Kristina Kantminienė | Yogesh Sutar |
Krzysztof Brzezinski | Yu Wen Hsu |
Kui Zhang | Yu-Chien Tseng |
Kumara Swami Konda | Yuliya Klymenko |
Kun Lyu | Yun Chen |
Kunhua Qin | Yunliang Zhang |
Kunihiro Tsuchida | Yves Combarnous |
Kyung In Baek | Zahra Gharari |
Lara Baticic | Zhaohai Wang |
Larisa Fedoreyeva | Zhaoqing Cong |
Laura Aracely Contreras-Angulo | Zhiyuan Wu |
Laurence Leherte | Zhonglei Wang |
Laurent Dufossé | Žiga Laznik |
Lei Huang | Zilvinas Anusevicius |
Leiz Véras | Zsolt Toth |
Leonid Bystrykh | Тatyana Odintsova |
9 January 2024
Meet Us at the 14th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 18–21 March 2024, Vienna, Austria

Conference: The 14th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
Date: 18–21 March 2024
Location: Vienna, Austria
MDPI will be attending the 14th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology at Booth #06, and we welcome researchers from different backgrounds to visit and share their latest ideas with us.
This conference has had an ever-increasing impact among pharmaceutical scientists, and it is organized every two years, in March or April of even years.
The entire spectrum of topics ranging from engineering aspects of the manufacturing process, the portfolio of commercially available excipients enabling the formulation of a large variety of medicinal products, the underlying physico-chemical principles, cutting-edge characterization techniques as well as potential pitfalls and hurdles to be overcome during product development, manufacturing and characterisation will be addressed.
Young and experienced scientists from academia and industry will present their latest research achievements in the form of poster presentations, allowing for fruitful scientific exchanges with the authors.
The meeting is intended to bring together people working in fundamental and applied academic research, in the chemical and pharmaceutical industry and the regulatory field, offering the opportunity to initiate fruitful discussions and collaborations.
The following MDPI journals will be represented:
- Pharmaceutics;
- Pharmaceuticals;
- IJMS;
- DDC;
- Molecules;
- Biomedicines;
- CIMB;
- Applied Biosciences;
- BioMedInformatics;
- Medicines;
- Cosmetics;
- Biomolecules.
2 January 2024
MDPI Insights: The CEO's Letter #7 - Nobel Laureates Entrust MDPI with Their Research

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Nobel Prize Laureates Entrust MDPI with Their Research
The Nobel Prize stands as a hallmark of distinction, honouring ground-breaking research across disciplines. Annually, the Nobel Prizes are awarded in six categories: Physics, Chemistry, Medicine or Physiology, Literature, Peace, and Economic Sciences.
Through the years, renowned scholars have entrusted MDPI with their work. As at December 2023, 26 Nobel laureates have contributed to more than 75 articles across 25 MDPI journals, including: Antibiotics, Applied Sciences, Biology, Biomedicines, Cancers, Catalysts, Cells, Crystals, Entropy, Games, IJMS, Life, Materials, Micromachines, Molecules, Pharmaceuticals, Pharmaceutics, Photonics, Quantum Beam Science, Remote Sensing, Sensors, Solids, Universe, Vaccines, and Viruses.
The best of the best trust us with their work.
Nobel Prize Laureates Who Have Published with MDPI
We are proud to list the names of Pierre Agostini, Hiroshi Amano, Werner Arber, Aaron Ciechanover, Robert H. Grubbs, Oliver Hart, Gerard ‘t Hooft, Michael Houghton, Harald zur Hausen, Katalin Karikó, Jean-Marie Lehn, Gérard Mourou, Ferid Murad, Shuji Nakamura, William Nordhaus, Kostya S. Novoselov, Giorgio Parisi, Charles M. Rice, Alvin E. Roth, Donna Strickland, K. Barry Sharpless, George F. Smoot, Anne L’Huillier, Drew Weissman, Kurt Wüthrich, Ada Yonath.
The privilege of hosting such contributors resonates deeply with our editorial teams. For instance, in this interview, the Editor-in-Chief (EiC) of Universe speaks on the significance of publishing a paper by Nobel laureate Gerard ’t Hooft within the journal.
2023 Nobel Prize Winners Published by MDPI
Nobel Prize Winners, 2023: Katalin Karikó, Drew Weissman, Anne L’Huillier (Ill. Niklas Elmehed © Nobel Prize Outreach)
Three laureates from the 2023 Nobel Prize cohort have trusted MDPI as their publishing platform. Notably, in a 2022 Pharmaceutics paper, molecular biologist Katalin Karikó and her team presented a methodology for evaluating mRNA capping efficiency, pivotal for therapeutic applications. Pharmaceutics had previously dedicated a Special Issue to “mRNA Therapeutics: A Themed Issue in Honor of Professor Katalin Karikó”, spotlighting ten articles from August 2021 to February 2022.
In the journal Vaccines, Professor Drew Weissman, collaborating with scholars from Pennsylvania University and George Mason University, contributed an influential review titled “Nanomaterial Delivery Systems for mRNA Vaccines”. His collaborative efforts spanned five papers across MDPI journals between 2021 and 2023.
Furthermore, Anne L'Huillier of Lund University, only the fifth female recipient of the Physics Prize, co-authored an article in Applied Sciences focusing on "Advanced EUV and X-Ray Optics". Similarly, Pierre Agostini, an Emeritus Professor from Ohio State University, co-authored an article featured in the special issue "Attosecond Science and Technology: Principles and Applications".
We extend heartfelt congratulations to all Nobel Prize laureates and express sincere gratitude for their confidence in MDPI as a platform for their scholarly contributions.
Read more:
Impactful Research
MDPI Journals Newly Indexed in 2023
The aim of indexing is to enhance the quality and credibility of published research, ensuring that researchers access the most credible resources available. While the principle behind citation indexing is straightforward, it remains one of the most dependable methods for tracking an idea's evolution across various scientific disciplines.
Throughout the year, MDPI works to expand the reach of our publications across premier multidisciplinary databases like Web of Science, Scopus, EBSCO, and ProQuest. This initiative is spearheaded by MDPI's Indexing team, under the leadership of Dr. Constanze Schelhorn.
In 2023, MDPI achieved 54 new acceptances in Scopus, 29 in Web of Science, 52 in EBSCO, and 83 in DOAJ: Directory of Open Access Journals.
The team prioritizes ensuring that our journals feature in numerous specialized databases, including PMC, PubMed, MEDLINE, Inspec, CAS, and FSTA, among others. Currently, MDPI collaborates with over 65 renowned international databases, consistently enhancing our database affiliations annually.
MDPI’s journals are indexed in all major global databases.
Furthermore, we collaborate with universities and government organizations to list our journals in country-specific ranking lists and relevant institutional repositories. This ensures compliance with requirements often set by funders or institutions for authors to publish in specific journals.
Web of Science Adds 24 MDPI Journals to Emerging Sources Citation Index (ESCI)
Clarivate recently analysed MDPI’s new journals, resulting in 24 journals, mainly established in 2020, being added to the ESCI in November and December 2023. Additionally, five journals passed this assessment earlier in the year. For a complete list of our journals in Web of Science, refer here. Journals in the ESCI meet 24 quality criteria, ensuring editorial rigor. They may be considered for inclusion in broader indices like the Science Citation Index Expanded (SCIE), the Social Sciences Citation Index (SSCI), or the Arts and Humanities Citation Index (AHCI), based on four impact criteria.
Read more:
Inside MDPI
MDPI Appoints New Chief Operating Officer (COO)
Alistair Freeland returned to MDPI and assumed the role of Chief Operating Officer in November 2023, a position he previously held from 2013 to 2019. He succeeds Dr. Yu Lin, who will remain a member of MDPI’s Board of Directors, overseeing significant financial decisions for the company. I would like to express my sincere thanks to Dr. Yu Lin for his service as COO.
Alistair brings extensive experience not only in scholarly publishing but also in technology and business management. Prior to rejoining MDPI, he was associated with SIX Group, the entity responsible for Switzerland's financial market infrastructure. There, he played a pivotal role in developing the blockchain-based platform SDX (SIX Digital Exchange), which has gained traction among major Swiss banks and the Swiss National Bank.
As COO, Alistair will collaborate with the MDPI management team to improve the practices and services we offer to scholarly communities. I am pleased to welcome Alistair back to MDPI and look forward to his contributions going forward.
Coming Together for Science
MDPI’s 2024 In-Person Academic Events Schedule
MDPI's Conference Team is dedicated to organizing and hosting in-person academic events across Europe, Asia-Pacific, and North America. We recognize conferences as invaluable platforms for scientific collaboration, scholarly exchange, discussions on contemporary topics, networking, and forging collaborations.
Here's a glimpse of the notable events we currently have scheduled for 2024:
|
14–16 February, 2024 |
|
24–26 April, 2024 |
|
28–31 May, 2024 |
|
1–4 August, 2024 |
Upcoming events with details to be announced:
- September 2024, Materials 2024 – Basel, Switzerland
- 19–21 September 2024, International Conference on Nanomaterials Sciences 2024 – Beijing, China
- October 2024, ncRNA 2024 – Basel, Switzerland
- November 2024, Pharmaceuticals 2024 – Barcelona, Spain
- 22–26 November 2024, International Conference on Science of Electronics – Wuhan, China
- Stay tuned for more details on the Sustainable Publishing Forum 2024.
Click here for all upcoming MDPI events.
Organize Your Event with MDPI’s Sciforum
Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.
Closing Thoughts
Reflecting on 2023 and Looking Ahead to 2024
As we approach 2024, I reflect on the incredible journey we’ve had together at MDPI this year. The past 12 months have been marked by ambitious projects and initiatives to improve our internal processes, and a commitment to continue delivering top-notch services to our stakeholders. I’d like to thank each and every one of our staff members for contributing to the positive experiences our stakeholders have reported in our surveys. Your dedication to speed, efficiency, and effective communication with our stakeholders is very much recognized and appreciated.
Becoming a stronger organisation
While we have encountered challenges in 2023, it’s important to understand that these are a part of our growth process. Difficulties provide us with opportunities to reflect, address problems at their roots, and ultimately evolve into a stronger organization. Our stakeholders expect us to overcome tough times, and it’s an expectation that we have for ourselves.
I extend my sincere appreciation to every MDPI employee, from our editorial office and IT department to marketing, indexing, IOAP, societies, Scientific Office board, products, production, conferences, finance, operations, admin, and beyond. To our newest team members, a warm welcome; to our longstanding colleagues, your dedication is invaluable.
“I am committed to taking MDPI to a new level of excellence.”
Interacting with many of you during my visits to our offices and representing MDPI at external events has been a personal highlight. I am deeply grateful to Dr. Lin for entrusting me with the role of CEO of MDPI. Looking forward, I am committed to working closely with our management team to lead MDPI and take it to a new level of excellence, aiming to establish it as the most trusted publisher in open access worldwide. This is a collective endeavour, with each of us shaping MDPI’s reputation. I therefore encourage us to take pride in our work, as it represents not only our craft but also MDPI as a whole.
Accountability and communication
As we look forward to 2024, there’s a lot to be excited about. Together, we’ll navigate challenges, seize growth opportunities, and refine our practices. To solidify MDPI’s position as the premier open access publisher globally, we must bolster accountability, improve stakeholder communication, share MDPI’s best practices, champion the open access philosophy, and educate stakeholders about our mission, methodologies, and motivations.
Thank you for engaging with the CEO Letter over the past six months of 2023. I will continue to release this newsletter as a method of sharing the great work being done at MDPI. Please feel free to connect directly with any insights or questions.
Here’s to a joyous and prosperous 2024!
Chief Executive Officer
MDPI AG